Reuters: Money News: Lupin gains on U.S. approval for eye drop generic

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Complimentary Downloads 7 Days of Complimentary Downloads: 100,000+ Motion Backgrounds, Video Clips, Production Music Tracks, Sound Effects, Special Effects and More. From our sponsors

Lupin gains on U.S. approval for eye drop generic Sep 2nd 2013, 08:11 Reuters Market Eye - Shares in Lupin Ltd gain 3.2 percent after the company got the final approval from the U.S. Food and Drug Administration for a generic version of eye drop Gatifloxacin on Friday, according to the web site of the U.S. regulator.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions